| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |